All Stories

  1. The TGF-β1 Signaling Pathway as an Attractive Target in the Fibrosis Pathogenesis of Sjögren’s Syndrome

    Article • Mediators of Inflammation, November 2018, Hindawi Publishing Corporation

    Margherita Sisto

  2. Downstream activation of NF-κB in the EDA-A1/EDAR signalling in Sjögren's syndrome and its regulation by the ubiquitin-editing enzyme A20

    Article • Clinical & Experimental Immunology, February 2016, Wiley

    Margherita Sisto

  3. Rituximab-mediated Raf kinase inhibitor protein induction modulates NF-κB in Sjögren syndrome

    Article • Immunology, July 2014, Wiley

    Margherita Sisto

  4. Neovascularization is prominent in the chronic inflammatory lesions of Sjögren's syndrome

    Article • International Journal of Experimental Pathology, November 2013, Wiley

    Margherita Sisto